Join the Event

Online registrations will be opening soon

CME CREDITS

Medical Surgeon (Clinical Pathology,
General Medicine (Family Doctors), Haematology, Internal Medicine, Medical Genetics, Nuclear Medicine, Oncology, Pathological Anatomy, Pharmacology and Clinical Toxicology, Radiology, Radiotherapy),
Biologist, Pharmacist,
Chemist
(Analytical Chemistry),
Physicist (Health Physics),
Veterinary

VENUE

Hotel NH Venezia Laguna Palace
Viale Ancona, 2
30172 – Venezia
Italy

OFFICIAL LANGUAGE

English
Simultaneous translation
will not be provided

ABSTRACT SUBMISSION

Abstract guidelines can be downloaded here.

Abstracts must be sent by July 15, 2022 and must focus on the following topics:

Abstract submission opens on June 1st, 2022.

  • Animal models of cancer
  • Cancer epidemiology
  • Cancer genetics, genomics and epigenetics
  • Cancer modeling and imaging
  • Cancer stem cells
  • Cell adhesion, migration, invasion and metastasis
  • Cell metabolism
  • DNA damage and molecular responses to damage
  • Drug resistance
  • Malignant pleural mesothelioma
  • Molecular pathology
  • Nanotechnology
  • Novel therapeutic targets and experimental therapeutics
  • Oncogenes and tumor suppressor genes
  • Pediatric cancer
  • Precision medicine
  • Prevention and early detection
  • Prognostic and predictive biomarkers
  • Signal transduction and intracellular trafficking
  • System biology and OMICS technologies
  • Tumor heterogeneity
  • Tumor immunology and immunotherapy
  • Tumor microenvironment: inflammation, hypoxia and angiogenesis

INTRODUCTION

The SIC Annual Meeting is the focal point of the Italian cancer research community, where preclinical and clinical scientists gather together to share the latest advances in cancer research and cure. In the last few years, we have witnessed, as never before, the rapid translation of preclinical research into clinical application.

The program of the 62nd SIC Annual Meeting, entitled “The exciting path from preclinical research to clinical application” will focus on the challenges posed by the rapid development of the precision medicine approaches, including the need for a better understanding of tumor heterogeneity and drug resistance mechanisms, and the ongoing efforts necessary for a better patients stratification for radio-,  chemo-, targeted- and immune- therapies, to increase the number of patients with durable clinical responses.

The meeting will be of interest for both preclinical and clinical researchers, working in different areas of cancer research.

In light of this broad attendance, we have designed scientific sessions in which most compelling topics will be discussed from different perspectives.

Participants to this CME event will thus have the opportunity to gain new knowledge and discuss several aspects of cancer research, including:

How particular targeted agents, radiotherapy and immunotherapies have been selected for their use, in patients with advanced cancer.

How to integrate the use of molecular profiling to select the most appropriate treatment for each patient.

How to evaluate the role of new emerging drugs and which is the biology underlying their efficacy.

Which are the main mechanisms of drug resistance and how combination therapies may increase treatment response or durability.

For the first time in Venice, SIC this year will also hold an open session dedicated to survivors, patients, care givers and all stakeholders involved in the cancer care. In an interactive round table, it will be discussed why and how research can impact on cancer prevention, treatment and patients’ quality of life.

REGISTRATION FEES

 RESIDENTIAL
Before September 16,
2022
RESIDENTIAL
After September 16,
2022
VIRTUAL
Before September 16,
2022
VIRTUAL
After September 16,
2022
SIC member420,00 €500,00 €150,00 €200,00 €
Young SIC member280,00 €330,00 €120,00 €150,00 €
Non member500,00 €600,00 €200,00 €250,00 €
Young non member380,00 €400,00 €150,00 €200,00 €

Registration fees include:

  • admission to the scientific sessions
  • admission to the exhibition area
  • name badge and congress kit
  • welcome cocktail
  • coffee breaks and light lunches
  • abstracts
  • attendance certificate
  • CME certificate
  • social dinner

REGISTRATION FEES

 RESIDENTIAL
Before September 16,
2022
RESIDENTIAL
After September 16,
2022
SIC member420,00 €500,00 €
Young SIC member280,00 €330,00 €
Non member500,00 €600,00 €
Young non member380,00 €400,00 €
 VIRTUAL
Before September 16,
2022
VIRTUAL
After September 16,
2022
SIC member150,00 €200,00 €
Young SIC member120,00 €150,00 €
Non member200,00 €250,00 €
Young non member150,00 €200,00 €

Registration fees include:

  • admission to the scientific sessions
  • admission to the exhibition area
  • name badge and congress kit
  • welcome cocktail
  • coffee breaks and light lunches
  • abstracts
  • attendance certificate
  • CME certificate
  • social dinner

PROGRAM

Vew and print the preliminary PDF program.

SCIENTIFIC COORDINATORS

Gustavo Baldassarre
Head of the Molecular Oncology Unit,
Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
National Cancer Institute (NCI), Aviano (PN), Italy

Fabio Puglisi
Head of the Department of Medical Oncology,
Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
National Cancer Institute (NCI), Aviano (PN), Italy
Professor of Medical Oncology,
Head of the School of Medical Oncology,
Department of Medicine, University of Udine, Italy.

LOCAL SCIENTIFIC
AND ORGANIZING COMMITTEE

Barbara Belletti
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)

Vincenzo Canzonieri
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)

Saverio Cinieri
“Sen. Antonio Perrino Hospital”, Brindisi – AIOM President

Pierfranco Conte
IRCCS Istituto Oncologico Veneto – University di Padova

Giannino Del Sal
University of Trieste – IFOM, Milan

Silvia Franceschi
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)

Valter Gattei
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)

Valentina Guarneri
IRCCS Istituto Oncologico Veneto – University di Padova

Stefano Indraccolo
IRCCS Istituto Oncologico Veneto – University di Padova

Roberta Maestro
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)

Michele Milella
University of Verona

Paolo Morandi
“Dell’Angelo” Hospital, Mestre (VE)

Flavio Rizzolio
University Ca’ Foscari, Venice

Aldo Scarpa
University of Verona

Agostino Steffan
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)

Gianluca Tell
University of Udine

SIC SCIENTIFIC BOARD

President

Nicola Normanno
National Cancer Institute, G. Pascale, Napoli

President Elect

Maurizio D’Incalci
Humanitas Research Hospital and Humanitas University, Milano

Past President

Gabriella Sozzi
Fondazione IRCCS National Cancer Institute, Milano

Members Under 35

Ilaria Guerriero
Biogem Institute for Genetic Research G. Salvatore, Ariano Irpino (AV)

Erica Torchiaro
Candiolo Cancer Institute FPO-IRCCS, Torino

Board

Paola Allavena
Humanitas Research Hospital, Milano

Gustavo Baldassarre
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)

Fabrizio Bianchi
IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG)

Giovanni Blandino
Regina Elena National Cancer Institute, Roma

Antonino Bruno
IRCCS MultiMedica, Milano

Paola Chiarugi
University of Firenze

Federica Di Nicolantonio
University of Torino and Candiolo Cancer Institute FPO-IRCCS

CONGRESS VENUE

A technical, pharmaceutical and publication exhibition will be held in the Congress Venue. For any information, please contact the Organizing Secretariat.

The 62th annual Meeting of the Italian Cancer Sociaty will take place in

Hotel NH Venezia Laguna Palace
Viale Ancona, 2
30172 – Venezia
Italy

GIORNATA APERTA

Venezia, Novembre 16th 2022

La SIC incontra la Società Civile
L’oncologia di precisione:
una realtà dalla prevenzione dalla terapia

Copyright 2022 Prospero Multilab Srl. All rights reserved